BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Campione E, Lanna C, Cosio T, Rosa L, Conte MP, Iacovelli F, Romeo A, Falconi M, Del Vecchio C, Franchin E, Lia MS, Minieri M, Chiaramonte C, Ciotti M, Nuccetelli M, Terrinoni A, Iannuzzi I, Coppeda L, Magrini A, Bernardini S, Sabatini S, Rosapepe F, Bartoletti PL, Moricca N, Di Lorenzo A, Andreoni M, Sarmati L, Miani A, Piscitelli P, Valenti P, Bianchi L. Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences. Front Pharmacol 2021;12:666600. [PMID: 34220505 DOI: 10.3389/fphar.2021.666600] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 31.0] [Reference Citation Analysis]
Number Citing Articles
1 Bolat E, Eker F, Kaplan M, Duman H, Arslan A, Saritaş S, Şahutoğlu AS, Karav S. Lactoferrin for COVID-19 prevention, treatment, and recovery. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.992733] [Reference Citation Analysis]
2 Sokolov AV, Isakova-Sivak IN, Mezhenskaya DA, Kostevich VA, Gorbunov NP, Elizarova AY, Matyushenko VA, Berson YM, Grudinina NA, Kolmakov NN, Zabrodskaya YA, Komlev AS, Semak IV, Budevich AI, Rudenko LG, Vasilyev VB. Molecular mimicry of the receptor-binding domain of the SARS-CoV-2 spike protein: from the interaction of spike-specific antibodies with transferrin and lactoferrin to the antiviral effects of human recombinant lactoferrin. Biometals 2022. [PMID: 36334191 DOI: 10.1007/s10534-022-00458-6] [Reference Citation Analysis]
3 Cutone A, Rosa L, Bonaccorsi di Patti MC, Iacovelli F, Conte MP, Ianiro G, Romeo A, Campione E, Bianchi L, Valenti P, Falconi M, Musci G. Lactoferrin Binding to SARS-CoV-2 Spike Glycoprotein Blocks Pseudoviral Entry and Relieves Iron Protein Dysregulation in Several In Vitro Models. Pharmaceutics 2022;14:2111. [PMID: 36297546 DOI: 10.3390/pharmaceutics14102111] [Reference Citation Analysis]
4 Morello R, De Rose C, Cardinali S, Valentini P, Buonsenso D. Lactoferrin as Possible Treatment for Chronic Gastrointestinal Symptoms in Children with Long COVID: Case Series and Literature Review. Children 2022;9:1446. [DOI: 10.3390/children9101446] [Reference Citation Analysis]
5 Saini J, Kaur P, Malik N, Lakhawat SS, Sharma PK. Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era. Microbiol Res 2022;265:127206. [PMID: 36162150 DOI: 10.1016/j.micres.2022.127206] [Reference Citation Analysis]
6 Darmawan KK, Karagiannis TC, Hughes JG, Small DM, Hung A. Molecular insights into the interaction of apo-lactoferrin with the receptor binding domain of the SARS-CoV-2 spike protein: a molecular dynamics simulation study. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2121759] [Reference Citation Analysis]
7 Krzyzowska M, Janicka M, Tomaszewska E, Ranoszek-Soliwoda K, Celichowski G, Grobelny J, Szymanski P. Lactoferrin-Conjugated Nanoparticles as New Antivirals. Pharmaceutics 2022;14:1862. [PMID: 36145610 DOI: 10.3390/pharmaceutics14091862] [Reference Citation Analysis]
8 Mohamed Y, El-maradny YA, Saleh AK, Nayl AA, El-gendi H, El-fakharany EM. A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment. Biomedicine & Pharmacotherapy 2022;153:113499. [DOI: 10.1016/j.biopha.2022.113499] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Dierick M, Ongena R, Vanrompay D, Devriendt B, Cox E. Lactoferrin Decreases Enterotoxigenic Escherichia coli-Induced Fluid Secretion and Bacterial Adhesion in the Porcine Small Intestine. Pharmaceutics 2022;14:1778. [DOI: 10.3390/pharmaceutics14091778] [Reference Citation Analysis]
10 Rosa L, Cutone A, Conte MP, Campione E, Bianchi L, Valenti P. An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection. Biometals 2022. [PMID: 35920949 DOI: 10.1007/s10534-022-00427-z] [Reference Citation Analysis]
11 Zauli G, Alhilali S, Al-swailem S, Secchiero P, Voltan R. Therapeutic potential of the MDM2 inhibitor Nutlin-3 in counteracting SARS-CoV-2 infection of the eye through p53 activation. Front Med 2022;9. [DOI: 10.3389/fmed.2022.902713] [Reference Citation Analysis]
12 Pang Z, Hu R, Tian L, Lou F, Chen Y, Wang S, He S, Zhu S, An X, Song L, Liu F, Tong Y, Fan H. Overview of Breastfeeding Under COVID-19 Pandemic. Front Immunol 2022;13:896068. [PMID: 35711421 DOI: 10.3389/fimmu.2022.896068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Telek E, Ujfalusi Z, Kemenesi G, Zana B, Jakab F, Hild G, Lukács A, Hild G. A Possible Way to Relate the Effects of SARS-CoV-2-Induced Changes in Transferrin to Severe COVID-19-Associated Diseases. IJMS 2022;23:6189. [DOI: 10.3390/ijms23116189] [Reference Citation Analysis]
14 Naidu SA, Clemens RA, Naidu AS. SARS-CoV-2 Infection Dysregulates Host Iron (Fe)-Redox Homeostasis (Fe-R-H): Role of Fe-Redox Regulators, Ferroptosis Inhibitors, Anticoagulants, and Iron-Chelators in COVID-19 Control. Journal of Dietary Supplements. [DOI: 10.1080/19390211.2022.2075072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Bartolomé F, Rosa L, Valenti P, Lopera F, Hernández-Gallego J, Cantero JL, Orive G, Carro E. Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer's Disease Patients. Front Immunol 2022;13:878201. [PMID: 35547737 DOI: 10.3389/fimmu.2022.878201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Piacentini R, Centi L, Miotto M, Milanetti E, Di Rienzo L, Pitea M, Piazza P, Ruocco G, Boffi A, Parisi G. Lactoferrin Inhibition of the Complex Formation between ACE2 Receptor and SARS CoV-2 Recognition Binding Domain. Int J Mol Sci 2022;23:5436. [PMID: 35628247 DOI: 10.3390/ijms23105436] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Iacovelli F, Costanza G, Romeo A, Cosio T, Lanna C, Bagnulo A, Di Maio U, Sbardella A, Gaziano R, Grelli S, Squillaci E, Miani A, Piscitelli P, Bianchi L, Falconi M, Campione E. Interaction of Pelargonium sidoides Compounds with Lactoferrin and SARS-CoV-2: Insights from Molecular Simulations. Int J Environ Res Public Health 2022;19:5254. [PMID: 35564648 DOI: 10.3390/ijerph19095254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 García-carnero LC, Mora-montes HM. Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis. JoF 2022;8:445. [DOI: 10.3390/jof8050445] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Lin T, Dadmohammadi Y, Davachi SM, Torabi H, Li P, Pomon B, Meletharayil G, Kapoor R, Abbaspourrad A. Improvement of lactoferrin thermal stability by complex coacervation using soy soluble polysaccharides. Food Hydrocolloids 2022. [DOI: 10.1016/j.foodhyd.2022.107736] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 de Jesus JR, Galazzi RM, Júnior CAL, Arruda MAZ. Trace element homeostasis in the neurological system after SARS-CoV-2 infection: insight into potential biochemical mechanisms. Journal of Trace Elements in Medicine and Biology 2022. [DOI: 10.1016/j.jtemb.2022.126964] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Gallo V, Giansanti F, Arienzo A, Antonini G. Antiviral properties of whey proteins and their activity against SARS-CoV-2 infection. J Funct Foods 2022;89:104932. [PMID: 35003332 DOI: 10.1016/j.jff.2022.104932] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
22 Wang X, Zhao Y, Wang T, Liang Y, Zhao X, Tang K, Guan Y, Wang H. Carboxyl-Rich Carbon Dots as Highly Selective and Sensitive Fluorescent Sensor for Detection of Fe3+ in Water and Lactoferrin. Polymers (Basel) 2021;13:4317. [PMID: 34960868 DOI: 10.3390/polym13244317] [Reference Citation Analysis]
23 Banu S, Idris MM, Nagaraj R. A proteomic perspective and involvement of cytokines in SARS-CoV-2 infection.. [DOI: 10.1101/2021.12.06.471525] [Reference Citation Analysis]
24 Presti S, Manti S, Parisi GF, Papale M, Barbagallo IA, Li Volti G, Leonardi S. Lactoferrin: Cytokine Modulation and Application in Clinical Practice. J Clin Med 2021;10:5482. [PMID: 34884183 DOI: 10.3390/jcm10235482] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
25 Gruden Š, Poklar Ulrih N. Diverse Mechanisms of Antimicrobial Activities of Lactoferrins, Lactoferricins, and Other Lactoferrin-Derived Peptides. Int J Mol Sci 2021;22:11264. [PMID: 34681923 DOI: 10.3390/ijms222011264] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
26 Campione E, Lanna C, Cosio T, Rosa L, Conte MP, Iacovelli F, Romeo A, Falconi M, Del Vecchio C, Franchin E, Lia MS, Minieri M, Chiaramonte C, Ciotti M, Nuccetelli M, Terrinoni A, Iannuzzi I, Coppeta L, Magrini A, Bernardini S, Sabatini S, Rosapepe F, Bartoletti PL, Moricca N, Di Lorenzo A, Andreoni M, Sarmati L, Miani A, Piscitelli P, Squillaci E, Valenti P, Bianchi L. Lactoferrin as Antiviral Treatment in COVID-19 Management: Preliminary Evidence. Int J Environ Res Public Health 2021;18:10985. [PMID: 34682731 DOI: 10.3390/ijerph182010985] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 17.0] [Reference Citation Analysis]
27 Barros CA, Sanches D, Marques de Carvalho CA, Santos RA, Ferraz de Souza TL, Macena Leite VL, Pereira da Costa Campos S, Cheble de Oliveira A, Gonçalves RB. Influence of iron binding in the structural stability and cellular internalization of bovine lactoferrin. Heliyon 2021;7:e08087. [PMID: 34632151 DOI: 10.1016/j.heliyon.2021.e08087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Orlova SV, Nikitina EA, Prokopenko EV, Volkova LY, Vodolazkaya AN. Immune properties of lactoferrin and its protective role in new coronavirus infection COVID-19. Medicinskij alfavit 2021. [DOI: 10.33667/2078-5631-2021-21-22-26] [Reference Citation Analysis]
29 Rosa L, Tripepi G, Naldi E, Aimati M, Santangeli S, Venditto F, Caldarelli M, Valenti P. Ambulatory COVID-19 Patients Treated with Lactoferrin as a Supplementary Antiviral Agent: A Preliminary Study. J Clin Med 2021;10:4276. [PMID: 34575388 DOI: 10.3390/jcm10184276] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]